FDA Adverse Event Injury Summary report: N

FLEXTEND

MDR report key: 3040762 · Received April 8, 2013

Report

Report Number
2124215-2013-01596
Event Type
Injury
Date Received
April 8, 2013
Date of Event
January 8, 2013
Report Date
September 19, 2013
Manufacturer
CPI - DEL CARIBE
Product Code
NVN
PMA / PMN Number
P960006
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
IN
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THE LEAD WAS SUBSEQUENTLY RETURNED FOR TESTING. THIS PRODUCT ISSUE WILL BE UPDATED WHEN EVALUATION IS COMPLETE.

Additional Manufacturer Narrative · 1

UPON RECEIPT IN OUR POST MARKET QUALITY ASSURANCE LABORATORY, A THOROUGH EVALUATION OF THE LEAD WAS PERFORMED. VISUAL INSPECTION DID NOT IDENTIFY ANY LEAD ABNORMALITIES. RESISTANCE AND PRESSURE TESTING CONFIRMED THE ELECTRICAL CONTINUITY AND INSULATION INTEGRITY OF THE LEAD. FINAL ANALYSIS COULD NOT CONFIRM THE REPORTED CLINICAL OBSERVATIONS.

Additional Manufacturer Narrative · 1

THE LEAD WILL NOT BE RETURNED FOR TESTING. THEREFORE, BOSTON SCIENTIFIC CANNOT CONFIRM THE REPORTED CLINICAL OBSERVATIONS. NO OTHER ADVERSE EVENTS HAVE BEEN REPORTED. THIS PRODUCT ISSUE WILL BE UPDATED IF ADDITIONAL INFORMATION IS RECEIVED.

Description of Event or Problem · 1

--

Description of Event or Problem · 1

--

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THIS PATIENT HAD TWIDDLED THIS ATRIAL LEAD TO THE POINT OF A FRACTURE AND NOW THE LEAD WAS PROTRUDING THROUGH THIS PATIENT'S SKIN. THERE WERE NO INAPPROPRIATE EPISODES STORED, NO INAPPROPRIATE THERAPY OR SYMPTOMS NOTED. A REVISION PROCEDURE WAS PERFORMED AND THE LEAD WAS REMOVED FROM SERVICE AND REPLACED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
143291 FLEXTEND IMPLANTABLE LEAD NVN CPI - DEL CARIBE 4086

Patients

Seq Age Sex Outcome Treatment
1 43 YR Hospitalization 4086| E110| 0184